DataMEDS AI launches new website after Helomics acquisition

DataMEDS AI, Inc. (NASDAQ: MEDS) launched a new corporate website following its acquisition of Helomics Corporation's AI Cancer Diagnostics Lab from Axe Compute and the settlement of litigation tied to its May 2023 acquisition of Wellgistics, LLC.

The litigation settlement resulted in the removal of approximately $19 million in liabilities from the company's balance sheet and the retirement of 364,099 common shares.

Gerald E. Commissiong, Interim Co-CEO of DataMEDS, said the company intends to soft launch its "Health Lives Here" consumer application in the near term. "Our new corporate website represents the parent company's new branding," Commissiong said. "We have retooled our marketing efforts to be AI-centric so that we are able to get organic traction online as we begin to draw earned media interest in our story."

DataMEDS AI, formerly known as Wellgistics Health, Inc., is headquartered in Tampa, Florida, and operates in health IT, pharmacy, and telemedicine services.

You May Also Be Interested In

• Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
• ATII shareholders approve merger with Forge Nano, listing as NANO on Nasdaq
• LQR House names Leo Chen as CEO, replacing Sean Dollinger